跳至主要内容
临床试验/JPRN-UMIN000014082
JPRN-UMIN000014082已完成未知

Evaluation of symptom relief in functional dyspepsia patients with PPI-resistant Gastroesophageal reflux disease -Acotiamide + standard-dose PPI vs double-dose PPI ; Prospective multi-center randomized study- - Evaluation of symptom relief in functional dyspepsia patients with PPI-resistant Gastroesophageal reflux disease -Acotiamide + standard-dose PPI vs double-dose PPI ; Prospective multi-center randomized study

Osaka Medical College0 个研究点目标入组 150 人开始时间: 2014年6月5日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
150

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Patients taking Gastric secretion inhibitors except Rabeprazole, Prokinetic agents except Acotiamide, and Chinese gastrointestinal medicine(Rikkunsito) after taking experimental drugs "study treatment" 2) Patients who received total gastrectomy 3) Patients with a chief complaint of IBS 4) Patients contraindicated for study treatment 5) Patients under 20 years old 6) Patients unsuited for this study at a physician's discretion

研究者

相似试验

Evaluation of symptom relief in functional dyspepsia... | 临床试验